These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 2711365)

  • 1. [Ritalin: a stimulating drug in the treatment of children with minimal brain dysfunction (MBD)].
    Flapper BC; Koopman HM; Heltzel A
    Tijdschr Kindergeneeskd; 1989 Feb; 57(1):14-20. PubMed ID: 2711365
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Prescribing ritalin in combined modality management of hyperactivity with attention deficit].
    Bricard C; Boidein F
    Encephale; 2001; 27(5):435-43. PubMed ID: 11760693
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Methylphenidat (Ritalin) as a psychotropic drug in children with minimal brain dysfunction and epilepsy].
    Kind CR
    Schweiz Med Wochenschr; 1975 Feb; 105(7):213-9. PubMed ID: 1121668
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A process for developing community consensus regarding the diagnosis and management of attention-deficit/hyperactivity disorder.
    Foy JM; Earls MF
    Pediatrics; 2005 Jan; 115(1):e97-104. PubMed ID: 15629972
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transdermal methylphenidate, behavioral, and combined treatment for children with ADHD.
    Pelham WE; Burrows-Maclean L; Gnagy EM; Fabiano GA; Coles EK; Tresco KE; Chacko A; Wymbs BT; Wienke AL; Walker KS; Hoffman MT
    Exp Clin Psychopharmacol; 2005 May; 13(2):111-26. PubMed ID: 15943544
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Multimodal therapy concept in hyperkinetic disorder. Drugs alone are not enough].
    Döpfner M; Frölich J; Sevecke K; Lehmkuhl G
    MMW Fortschr Med; 2002 Nov; 144(47):34-8. PubMed ID: 12532520
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Benefit of the extended-release methylphenidate formulations: a comparative study in childhood].
    Favreau A; Deseille-Turlotte G; Brault F; Giraudeau B; Krier C; Barthez MA; Castelnau P
    Arch Pediatr; 2006 May; 13(5):442-8. PubMed ID: 16597499
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Attention deficit hyperactivity disorder: pharmacological options that are not "Ritalin"].
    Shmueli D; Gross-Tsur V
    Harefuah; 2005 Aug; 144(8):572-6, 597. PubMed ID: 16146157
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The effects of psychostimulants on the cognitive results and behaviour of children with the combined subtype of attention deficit with hyperactivity].
    Mulas F; Roselló B; Morant A; Hernández S; Pitarch I
    Rev Neurol; 2002 Jul 1-15; 35(1):17-24. PubMed ID: 12389187
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Therapy program for children with hyperkinetic and oppositional problem behavior--organization and single case evaluation].
    Döpfner M; Lehmkuhl G; Schürmann S
    Z Kinder Jugendpsychiatr Psychother; 1996 Sep; 24(3):145-63. PubMed ID: 9459672
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The acceptability of interventions for attention-deficit hyperactivity disorder among elementary and middle school teachers.
    Power TJ; Hess LE; Bennett DS
    J Dev Behav Pediatr; 1995 Aug; 16(4):238-43. PubMed ID: 7593658
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Psychosocial treatments for attention-deficit/hyperactivity disorder in children.
    Barkley RA
    J Clin Psychiatry; 2002; 63 Suppl 12():36-43. PubMed ID: 12562060
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ritalin and MBD: a cure in search of a disease.
    Messinger E
    Health PAC Bull; 1975; (67):1-9, 18-21. PubMed ID: 10237682
    [No Abstract]   [Full Text] [Related]  

  • 14. Pleasure and discipline in the uses of Ritalin.
    Keane H
    Int J Drug Policy; 2008 Oct; 19(5):401-9. PubMed ID: 17884422
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Urinary 3-methoxy-4-hydroxyphenylglycol sulfate excretion in seventy-three schoolchildren with minimal brain dysfunction syndrome.
    Shen YC; Wang YF
    Biol Psychiatry; 1984 Jun; 19(6):861-70. PubMed ID: 6743722
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Methylphenidate and cognitive therapy in children with attention deficit disorder: a double-blind trial.
    Brown RT; Wynne ME; Borden KA; Clingerman SR; Geniesse R; Spunt AL
    J Dev Behav Pediatr; 1986 Jun; 7(3):163-74. PubMed ID: 3522630
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Attention in hyperkinetic children: a signal detection analysis of the effect of methylphenidate].
    Rossel E
    Z Kinder Jugendpsychiatr; 1987; 15(1):6-17. PubMed ID: 3554818
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Individual responses to methylphenidate and caffeine in children with minimal brain dysfunction.
    Garfinkel BD; Webster CD; Sloman L
    Can Med Assoc J; 1975 Oct; 113(8):729-32. PubMed ID: 803184
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A long-term comparison of two treatment regimens for minimal brain dysfunction. Drug therapy versus combined therapy.
    Friedman R; Dale EP; Wagner JH
    Clin Pediatr (Phila); 1973 Nov; 12(11):666-71. PubMed ID: 4759509
    [No Abstract]   [Full Text] [Related]  

  • 20. Attention deficit hyperactivity disorder in children.
    Pritchard D
    Clin Evid; 2005 Jun; (13):266-79. PubMed ID: 16135263
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.